1 – 10 of 56
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
The challenge of recruiting multimorbid older patients identified in a hospital database to a randomised controlled trial
- Contribution to journal › Article
- 2019
-
Mark
Sex differences in predictors of mortality in patients with Alzheimer’s disease – A 20-year follow-up.
(2019) 14th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2019)
- Contribution to conference › Abstract
-
Mark
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
- Contribution to journal › Article
-
Mark
Sex differences in predictors of cognitive and functional outcomes in patients with Alzheimer’s disease.
(2019) 12th Clinical Trials on Alzheimer’s Disease Conference
- Contribution to conference › Poster
-
Mark
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE) : a modelling study
- Contribution to journal › Article
- 2018
-
Mark
Association of cerebral amyloid-β Aggregation with cognitive functioning in persons without dementia
- Contribution to journal › Article
-
Mark
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
- Contribution to journal › Article
- 2017
-
Mark
Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid
- Contribution to journal › Article
-
Mark
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes
- Contribution to journal › Article
-
Mark
Cerebrovascular and amyloid pathology in predementia stages : The relationship with neurodegeneration and cognitive decline
- Contribution to journal › Article
